logo

For the Inventor, By the Inventor

Randolph, NJ, United States of America

Wendy Lea Corbett

USPTO Granted Patents = 20

Average Co-Inventor Count = 4.6

ph-index = 10

Forward Citations = 354(Granted Patents)


Location History:

  • Randolph, NJ (US) (2000 - 2007)
  • Lebanon, NJ (US) (2006 - 2012)

Company Filing History:

goldMedal19 out of 4,945 
 
Hoffmann-la Roche Inc.
 patents
silverMedal1 out of 832,843 
Other
 patents

Years Active: 2000-2012

Loading Chart...
20 patents (USPTO):Explore Patents
1. 8222416 - Azaindole glucokinase activators (2012-07-17),
2. 7534593 - Crystals of glucokinase and methods of growing them (2009-05-19),
3. 7259166 - Substituted-cycloalkyl and oxygenated-cycloalkyl glucokinase activators (2007-08-21),
4. 7223868 - Heteroaromatic glucokinase activators (2007-05-29),
5. 7132425 - 5-substituted-six-membered heteroaromatic glucokinase activators (2006-11-07),
6. 7105671 - Substituted-cycloalkyl and oxygenated-cycloalkyl glucokinase activators (2006-09-12),
7. 6951945 - Heteroaromatic glucokinase activators (2005-10-04),
8. 6911545 - Crystals of glucokinase and methods of growing them (2005-06-28),
9. 6881844 - Indole-3-carboxamides as glucokinase activators (2005-04-19),
10. 6610846 - Heteroaromatic glucokinase activators (2003-08-26),
11. 6545155 - Fused heteroaromatic glucokinase activators (2003-04-08),
12. 6528543 - Urea derivatives (2003-03-04),
13. 6448399 - Fused heteroaromatic glucokinase activators (2002-09-10),
14. 6441184 - Fused heteroaromatic glucokinase activators (2002-08-27),
15. 6433188 - Fused heteroaromatic glucokinase activators (2002-08-13),

Title: Unveiling the Innovations of Wendy Lea Corbett

Introduction:

Wendy Lea Corbett, a brilliant inventor hailing from Randolph, NJ, has made significant strides in the field of pharmaceuticals and structural biology. With a remarkable portfolio of 20 patents, her contributions have been pivotal in the treatment of metabolic diseases such as type II diabetes mellitus.

Latest Patents:

Among Wendy Lea Corbett's latest patents is the groundbreaking work on Azaindole glucokinase activators. These compounds, designed to treat metabolic disorders, offer promising solutions for individuals suffering from conditions like type II diabetes mellitus. Additionally, her work on the crystalline forms of mammalian Glucokinase has revolutionized the field of structural biology, providing valuable insights through X-ray crystallography.

Career Highlights:

Wendy Lea Corbett has garnered her expertise through her tenure at Hoffmann-La Roche Inc. (presented as Roche) where she honed her skills and garnered invaluable experience in pharmaceutical research and development. Her innovative approach to drug discovery has set her apart as a trailblazer in the industry.

Collaborations:

Throughout her career, Wendy Lea Corbett has collaborated with esteemed professionals such as Nancy-Ellen Haynes and Ramakanth Sarabu. Together, they have spearheaded projects that have reshaped the landscape of pharmaceutical research, setting new standards for innovation and scientific discovery.

Conclusion:

In conclusion, Wendy Lea Corbett's dedication to advancing the field of pharmaceuticals and structural biology is truly commendable. Her groundbreaking patents and collaborations stand as a testament to her unwavering commitment to improving healthcare outcomes and shaping a better future for all.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…